EXPLORE THE SCIENCE
Anti-cancer peptides (ACPs) offer a potentially more targeted way to detect and treat cancer compared to conventional therapies like chemotherapy. ACPs can discriminate between cancerous and healthy cells, resulting in fewer side effects. Key Facts: ACPs can a…
Read article
The NLRP3 inflammasome is increasingly being recognized as a mediator between inflammation and depression. Targeting this molecular complex shows promise for developing new antidepressant therapies. Key Facts: The NLRP3 inflammasome is made up of NLRP3, ASC, a…
Read article
The naturally occurring peptide BPC 157 shows potential to treat stroke, schizophrenia symptoms, and spinal cord injury in animal models. Key facts: BPC 157 rapidly counteracted stroke damage and led to full recovery of memory, coordination and movement in rat…
Read article
People struggling with substance use disorders often have difficulties with memory, attention, planning, and decision-making. New research explores how these cognitive deficits relate to treatment outcomes and whether targeting them could improve addiction rec…
Read article
Researchers uncover a surprising molecular mechanism that explains ketamine’s exceptionally long-lasting antidepressant effects. Key Facts: Ketamine’s antidepressant effects last for days after its concentration drops to low, ineffective levels only an hour af…
Read article
Depression is one of the most common mental health issues, affecting over 320 million people globally. Research shows that exercise may be an effective treatment option for many battling this disabling condition. Key Facts: Exercise has comparable antidepressa…
Read article
Researchers have discovered that several commonly prescribed antidepressants can promote antibiotic resistance and persistence in E. coli bacteria. This concerning finding implicates yet another widely used class of pharmaceuticals in exacerbating the global a…
Read article
Researchers conducted a comprehensive analysis comparing 20 antidepressants to identify the most effective options for preventing relapse in patients with major depressive disorder (MDD). Their findings suggest desvenlafaxine, paroxetine, venlafaxine and vorti…
Read article
Antidepressant medications like bupropion (Zyban) show potential to help people quit smoking long-term. However, the evidence is complex with both benefits and risks to consider carefully. Key facts: The antidepressant bupropion (brand name Zyban) aids quittin…
Read article
Cognitive enhancement techniques hold great promise for boosting our mental abilities, but they may also come with hidden costs according to new research. Key Facts: Cognitive enhancement aims to improve mental functioning in healthy people through methods lik…
Read article